Please assess the completion status of the following clinical trial:

Trial Title: Duration of Doxycycline Treatment in EM Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* solitary erythema migrans~Exclusion Criteria:~* pregnancy or lactation~* immunocompromised~* serious adverse event to doxycycline~* taking antibiotic with antiborrelial activity within 10 days~* multiple erythema migrans or extracutaneous manifestations of lyme borreliosis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- EM-7 days doxycycline (Type: ACTIVE_COMPARATOR): None
- EM-14 days doxycycline (Type: ACTIVE_COMPARATOR): None
- Controls (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).